## Alcohol Withdrawal Syndrome: Acute Management ### Clinical Context This patient presents with **early-to-intermediate alcohol withdrawal** (tremor, diaphoresis, autonomic hyperactivity 18 hours post-cessation). The hypomagnesemia (1.4 mg/dL; normal 1.7–2.2) and hyponatremia (128 mEq/L) are common complications that lower seizure threshold. ### Why Lorazepam Is Correct **Key Point:** Benzodiazepines are the gold standard for alcohol withdrawal. Lorazepam is preferred over diazepam in acute settings because of: - Rapid onset (IV administration) - Shorter half-life (12–18 hours) → less accumulation in elderly or hepatically impaired patients - Can be titrated to effect ("symptom-triggered" dosing) - Effective for both seizure prophylaxis and autonomic stabilization **High-Yield:** The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol scale) score guides benzodiazepine dosing. Scores ≥8 warrant pharmacotherapy; scores ≥15 indicate severe withdrawal requiring ICU monitoring. ### Electrolyte Correction **Clinical Pearl:** Hypomagnesemia must be corrected concurrently (IV magnesium sulfate 1–2 g over 15 min, then infusion) because magnesium deficiency: - Increases seizure risk independent of alcohol withdrawal - Impairs cardiac repolarization (risk of arrhythmia) - Reduces benzodiazepine efficacy Hyponatremia should be corrected cautiously (0.5–1 mEq/L/hour) to avoid osmotic demyelination. ### Supportive Measures - **Thiamine 100 mg IV/IM daily** (prevent Wernicke encephalopathy) - **Folic acid 1 mg daily** (nutritional repletion) - **Glucose monitoring** (risk of hypoglycemia post-withdrawal) [cite:Harrison 21e Ch 474]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.